Insufficient scRNA-seq data for expression of MMP13 at single-cell level.
Insufficient scRNA-seq data for expression of MMP13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ureter | 0% | 0 | 0 / 0 | 100% | 8.92 | 1 / 1 |
breast | 23% | 4.47 | 107 / 459 | 70% | 42.06 | 783 / 1118 |
lung | 38% | 25.00 | 222 / 578 | 50% | 65.87 | 574 / 1155 |
bladder | 43% | 10.38 | 9 / 21 | 40% | 26.67 | 201 / 504 |
skin | 58% | 15.94 | 1043 / 1809 | 25% | 9.77 | 116 / 472 |
esophagus | 8% | 1.79 | 112 / 1445 | 40% | 56.61 | 73 / 183 |
prostate | 42% | 30.08 | 102 / 245 | 2% | 0.28 | 9 / 502 |
uterus | 4% | 0.66 | 7 / 170 | 39% | 67.71 | 180 / 459 |
tonsil | 0% | 0 | 0 / 0 | 40% | 38.45 | 18 / 45 |
adipose | 28% | 6.28 | 341 / 1204 | 0% | 0 | 0 / 0 |
intestine | 15% | 2.48 | 148 / 966 | 13% | 2.10 | 67 / 527 |
pancreas | 2% | 0.32 | 5 / 328 | 21% | 9.57 | 37 / 178 |
ovary | 0% | 0 | 0 / 180 | 21% | 7.14 | 92 / 430 |
stomach | 6% | 0.58 | 23 / 359 | 14% | 2.25 | 39 / 286 |
thymus | 6% | 0.84 | 38 / 653 | 12% | 2.74 | 74 / 605 |
kidney | 13% | 0.74 | 12 / 89 | 2% | 1.24 | 20 / 901 |
blood vessel | 11% | 138.05 | 142 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 7% | 0.43 | 17 / 258 | 1% | 0.33 | 2 / 230 |
spleen | 7% | 0.38 | 17 / 241 | 0% | 0 | 0 / 0 |
brain | 3% | 0.23 | 88 / 2642 | 2% | 2.04 | 13 / 705 |
muscle | 3% | 0.52 | 23 / 803 | 0% | 0 | 0 / 0 |
liver | 1% | 0.08 | 3 / 226 | 1% | 0.33 | 5 / 406 |
peripheral blood | 1% | 0.34 | 13 / 929 | 0% | 0 | 0 / 0 |
heart | 1% | 0.05 | 9 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_0060349 | Biological process | bone morphogenesis |
GO_1904645 | Biological process | response to amyloid-beta |
GO_0003417 | Biological process | growth plate cartilage development |
GO_0030574 | Biological process | collagen catabolic process |
GO_0001958 | Biological process | endochondral ossification |
GO_0006508 | Biological process | proteolysis |
GO_0030282 | Biological process | bone mineralization |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0031012 | Cellular component | extracellular matrix |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005518 | Molecular function | collagen binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | MMP13 |
Protein name | Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13) Alternative protein MMP13 Matrix metalloproteinase 13 Collagenase 3 (Matrix metalloproteinase-13) |
Synonyms | hCG_39650 |
Description | FUNCTION: Plays a role in the degradation of extracellular matrix proteins including fibrillar collagen, fibronectin, TNC and ACAN. Cleaves triple helical collagens, including type I, type II and type III collagen, but has the highest activity with soluble type II collagen. Can also degrade collagen type IV, type XIV and type X. May also function by activating or degrading key regulatory proteins, such as TGFB1 and CCN2. Plays a role in wound healing, tissue remodeling, cartilage degradation, bone development, bone mineralization and ossification. Required for normal embryonic bone development and ossification. Plays a role in the healing of bone fractures via endochondral ossification. Plays a role in wound healing, probably by a mechanism that involves proteolytic activation of TGFB1 and degradation of CCN2. Plays a role in keratinocyte migration during wound healing. May play a role in cell migration and in tumor cell invasion. . FUNCTION: Plays a role in the degradation of extracellular matrix proteins including fibrillar collagen, fibronectin, TNC and ACAN. Cleaves triple helical collagens, including type I, type II and type III collagen, but has the highest activity with soluble type II collagen. Can also degrade collagen type IV, type XIV and type X. May also function by activating or degrading key regulatory proteins, such as TGFB1 and CCN2. Plays a role in wound healing, tissue remodeling, cartilage degradation, bone development, bone mineralization and ossification. Required for normal embryonic bone development and ossification. Plays a role in the healing of bone fractures via endochondral ossification. Plays a role in wound healing, probably by a mechanism that involves proteolytic activation of TGFB1 and degradation of CCN2. Plays a role in keratinocyte migration during wound healing. May play a role in cell migration and in tumor cell invasion. . |
Accessions | L8EA04 G5E971 L0R508 A0A4P8LAY1 P45452 ENST00000260302.8 ENST00000340273.4 |